F.D.A. Approves New Drug to Treat Vaginal Yeast Infections

The Food and Drug Administration on Tuesday approved a new drug to treat a vaginal yeast infection that is especially common in women wh...


The Food and Drug Administration on Tuesday approved a new drug to treat a vaginal yeast infection that is especially common in women who are pregnant, using birth control pills or taking antibiotics.

The drug, Brexafemme (ibrexafungerp) made by SCYNEXIS, is a one-day oral treatment and the first of a new class of triterpenoid antifungal drugs. The company said the new drug kills candida — the yeast that can cause an infection.

The standard oral medication, Diflucan (fluconazole), inhibits the growth of yeast but does not kill it.

But the treatment most likely wouldn’t be prescribed widely at first for common vaginal yeast infections. Dr. David Angulo, the company’s chief medical officer, estimated that the list price of the drug would range from $350 to $450 for the four-tablet treatment. By comparison, GoodRx lists the average retail price of fluconazole as $29.81.

He said Brexafemme was approved as a first-line treatment, but could also be prescribed for patients whose infections don’t clear up easily.

“There has been nothing new that can be provided to patients who can’t tolerate it, don’t respond well or develop resistance,” Dr. Angulo said.

Dr. Sumathi Nambiar, director of the F.D.A.’s division of anti-infectives said: “This approval for a new antifungal drug provides an additional treatment option for patients with vulvovaginal candidiasis, or vaginal or vulvar yeast infections, and represents another step forward in the F.D.A.’s overall efforts to ensure safe and effective antifungal drugs are available to patients.”

Dr. Denise Jamieson, chair of gynecology and obstetrics at Emory University School of Medicine, said she wasn’t sure the new drug was needed.

“I don’t see a tremendous amount of resistance,” she said. “I can’t really comment on whether this is going to be a large addition or not. It’s always helpful to have another option, and then you have to consider things like cost and tolerability.”

According to Dr. Angulo, one clinical trial used to support the application showed 50 percent efficacy — meaning complete resolution of all signs and symptoms — at 10 days after treatment and 60 percent 25 days after treatment. The other trial showed 64 percent efficacy at day 10 and 73 percent at day 25.

Dr. Michael Carome, director of Public Citizen’s Health Research Group, was not impressed by the F.D.A.’s approval of Brexafemme.

“This drug is not necessary and few women should need it,” Dr. Carome said. “Fluconazole is available at very low cost and in general is very effective. The cost of this is just outrageous.”

The F.D.A. is requiring SCYNEXIS to conduct several post-market studies, including one to assess the risks to pregnant women, the developing fetus and newborns; and another to study how much of the product goes into the breast milk of lactating women.

The drug will go on sale later this year.

Source Link

COMMENTS

Name

Africa,824,Americas,4130,Art & Culture,15021,Arts,6521,Arts & Design,1684,Asia,3300,Automobile,465,Baseball,640,Basketball,535,Books,3913,Business,5370,Celebrity,2633,Cricket,648,Crime,158,Cryptocurrency,1601,Dance,675,Defense,836,Diplomatic Relations,2496,Economy,1155,Editorial,260,Education,1263,Elections,308,Energy & Environment,3079,Entertainment,22762,Environment,3632,Europe,4248,Faith & Religion,235,Family & Life,817,Fashion & Style,3285,Finance,20075,Food & Drink,3769,Football,1112,Games,97,Gossip,10289,Health & Fitness,4114,Health Care,939,Hockey,229,Home & Garden,920,Humour,994,Latin America,49,Lifestyle,17167,Media,527,Middle East,1548,Movies,1745,Music,2668,Opinion,3118,Other,11997,Other Sports,5072,Political News,11324,Political Protests,2324,Politics,17785,Real Estate,1884,Relationship,106,Retail,3116,Science,2653,Science & Tech,10093,Soccer,247,Space & Cosmos,351,Sports,12310,Technology,3457,Tennis,582,Theater,1698,Transportation,313,Travel,2585,TV,3708,US,350,US Sports,1481,Video News,3531,War & Conflict,1069,Weird News,998,World,16602,
ltr
item
Newsrust - US Top News: F.D.A. Approves New Drug to Treat Vaginal Yeast Infections
F.D.A. Approves New Drug to Treat Vaginal Yeast Infections
https://static01.nyt.com/images/2021/06/02/science/02FDA-DRUG1/02FDA-DRUG1-facebookJumbo.jpg
Newsrust - US Top News
https://www.newsrust.com/2021/06/fda-approves-new-drug-to-treat-vaginal.html
https://www.newsrust.com/
https://www.newsrust.com/
https://www.newsrust.com/2021/06/fda-approves-new-drug-to-treat-vaginal.html
true
732247599994189300
UTF-8
Loaded All Posts Not found any posts VIEW ALL Readmore Reply Cancel reply Delete By Home PAGES POSTS View All RECOMMENDED FOR YOU LABEL ARCHIVE SEARCH ALL POSTS Not found any post match with your request Back Home Sunday Monday Tuesday Wednesday Thursday Friday Saturday Sun Mon Tue Wed Thu Fri Sat January February March April May June July August September October November December Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec just now 1 minute ago $$1$$ minutes ago 1 hour ago $$1$$ hours ago Yesterday $$1$$ days ago $$1$$ weeks ago more than 5 weeks ago Followers Follow THIS PREMIUM CONTENT IS LOCKED STEP 1: Share to a social network STEP 2: Click the link on your social network Copy All Code Select All Code All codes were copied to your clipboard Can not copy the codes / texts, please press [CTRL]+[C] (or CMD+C with Mac) to copy Table of Content